Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

A proline-rich motif on VGLUT1 reduces synaptic vesicle super-pool and spontaneous release frequency.

Zhang XM, François U, Silm K, Angelo MF, Fernandez-Busch MV, Maged M, Martin C, Bernard V, Cordelières FP, Deshors M, Pons S, Maskos U, Bemelmans AP, Wojcik SM, El Mestikawy S, Humeau Y, Herzog E.

Elife. 2019 Oct 30;8. pii: e50401. doi: 10.7554/eLife.50401.

2.

Profound alteration in reward processing due to a human polymorphism in CHRNA5: a role in alcohol dependence and feeding behavior.

Besson M, Forget B, Correia C, Blanco R, Maskos U.

Neuropsychopharmacology. 2019 Oct;44(11):1906-1916. doi: 10.1038/s41386-019-0462-0. Epub 2019 Jul 9.

PMID:
31288250
3.

A Human Polymorphism in CHRNA5 Is Linked to Relapse to Nicotine Seeking in Transgenic Rats.

Forget B, Scholze P, Langa F, Morel C, Pons S, Mondoloni S, Besson M, Durand-de Cuttoli R, Hay A, Tricoire L, Lambolez B, Mourot A, Faure P, Maskos U.

Curr Biol. 2018 Oct 22;28(20):3244-3253.e7. doi: 10.1016/j.cub.2018.08.044. Epub 2018 Oct 4.

4.

Manipulating midbrain dopamine neurons and reward-related behaviors with light-controllable nicotinic acetylcholine receptors.

Durand-de Cuttoli R, Mondoloni S, Marti F, Lemoine D, Nguyen C, Naudé J, d'Izarny-Gargas T, Pons S, Maskos U, Trauner D, Kramer RH, Faure P, Mourot A.

Elife. 2018 Sep 4;7. pii: e37487. doi: 10.7554/eLife.37487.

5.

Mitochondrial Nicotinic Acetylcholine Receptors Support Liver Cells Viability After Partial Hepatectomy.

Uspenska K, Lykhmus O, Obolenskaya M, Pons S, Maskos U, Komisarenko S, Skok M.

Front Pharmacol. 2018 Jun 13;9:626. doi: 10.3389/fphar.2018.00626. eCollection 2018.

6.

Alpha6-Containing Nicotinic Acetylcholine Receptors Mediate Nicotine-Induced Structural Plasticity in Mouse and Human iPSC-Derived Dopaminergic Neurons.

Collo G, Cavalleri L, Zoli M, Maskos U, Ratti E, Merlo Pich E.

Front Pharmacol. 2018 Jun 1;9:572. doi: 10.3389/fphar.2018.00572. eCollection 2018.

7.

Positive allosteric modulators of α7* or β2* nicotinic acetylcholine receptors trigger different kinase pathways in mitochondria.

Uspenska K, Lykhmus O, Arias HR, Pons S, Maskos U, Komisarenko S, Skok M.

Int J Biochem Cell Biol. 2018 Jun;99:226-235. doi: 10.1016/j.biocel.2018.04.018. Epub 2018 Apr 25.

PMID:
29704624
8.

Relevance of treated cocaine users' retrospective memory of first cocaine use.

Karsinti E, Piani K, Zerdazi EH, Maskos U, Faure P, Romo L, Bellivier F, Brousse G, Lépine JP, Bloch V, Vorspan F.

Psychiatry Res. 2018 Jun;264:210-216. doi: 10.1016/j.psychres.2018.03.058. Epub 2018 Mar 29.

PMID:
29653350
9.

Nicotinic receptors mediate stress-nicotine detrimental interplay via dopamine cells' activity.

Morel C, Fernandez SP, Pantouli F, Meye FJ, Marti F, Tolu S, Parnaudeau S, Marie H, Tronche F, Maskos U, Moretti M, Gotti C, Han MH, Bailey A, Mameli M, Barik J, Faure P.

Mol Psychiatry. 2018 Jul;23(7):1597-1605. doi: 10.1038/mp.2017.145. Epub 2017 Jul 25.

PMID:
29155800
10.

Transcriptome of melanoma cells from two mouse models, Tyr:NRasQ61K and Tyr:Rack1-HA, Tyr:NRasQ61K.

Campagne C, Pons S, Esquerre D, Estellé J, Bourneuf E, Maskos U, Egidy G.

Data Brief. 2017 Jul 11;14:32-34. doi: 10.1016/j.dib.2017.07.006. eCollection 2017 Oct.

11.

GluD1, linked to schizophrenia, controls the burst firing of dopamine neurons.

Benamer N, Marti F, Lujan R, Hepp R, Aubier TG, Dupin AAM, Frébourg G, Pons S, Maskos U, Faure P, Hay YA, Lambolez B, Tricoire L.

Mol Psychiatry. 2018 Mar;23(3):691-700. doi: 10.1038/mp.2017.137. Epub 2017 Jul 11.

12.

RACK1 cooperates with NRASQ61K to promote melanoma in vivo.

Campagne C, Reyes-Gomez E, Picco ME, Loiodice S, Salaun P, Ezagal J, Bernex F, Commère PH, Pons S, Esquerre D, Bourneuf E, Estellé J, Maskos U, Lopez-Bergami P, Aubin-Houzelstein G, Panthier JJ, Egidy G.

Cell Signal. 2017 Aug;36:255-266. doi: 10.1016/j.cellsig.2017.03.015. Epub 2017 Mar 24.

PMID:
28343944
13.

Nicotine reverses hypofrontality in animal models of addiction and schizophrenia.

Koukouli F, Rooy M, Tziotis D, Sailor KA, O'Neill HC, Levenga J, Witte M, Nilges M, Changeux JP, Hoeffer CA, Stitzel JA, Gutkin BS, DiGregorio DA, Maskos U.

Nat Med. 2017 Mar;23(3):347-354. doi: 10.1038/nm.4274. Epub 2017 Jan 23.

14.

Early and progressive deficit of neuronal activity patterns in a model of local amyloid pathology in mouse prefrontal cortex.

Koukouli F, Rooy M, Maskos U.

Aging (Albany NY). 2016 Dec 20;8(12):3430-3449. doi: 10.18632/aging.101136.

15.

Nicotinic receptors in mouse prefrontal cortex modulate ultraslow fluctuations related to conscious processing.

Koukouli F, Rooy M, Changeux JP, Maskos U.

Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):14823-14828. doi: 10.1073/pnas.1614417113. Epub 2016 Dec 2.

16.

Human polymorphisms in nicotinic receptors: a functional analysis in iPS-derived dopaminergic neurons.

Deflorio C, Blanchard S, Carisì MC, Bohl D, Maskos U.

FASEB J. 2017 Feb;31(2):828-839. doi: 10.1096/fj.201600932R. Epub 2016 Nov 17.

PMID:
27856558
17.

Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets.

Li T, Vandesquille M, Koukouli F, Dudeffant C, Youssef I, Lenormand P, Ganneau C, Maskos U, Czech C, Grueninger F, Duyckaerts C, Dhenain M, Bay S, Delatour B, Lafaye P.

J Control Release. 2016 Dec 10;243:1-10. doi: 10.1016/j.jconrel.2016.09.019. Epub 2016 Oct 6.

18.

A role for β2* nicotinic receptors in a model of local amyloid pathology induced in dentate gyrus.

Lombardo S, Catteau J, Besson M, Maskos U.

Neurobiol Aging. 2016 Oct;46:221-34. doi: 10.1016/j.neurobiolaging.2016.06.005. Epub 2016 Jun 17.

PMID:
27522251
19.

Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments.

Besson M, Guiducci S, Granon S, Guilloux JP, Guiard B, Repérant C, Faure P, Pons S, Cannazza G, Zoli M, Gardier AM, Maskos U.

Psychopharmacology (Berl). 2016 Sep;233(18):3297-314. doi: 10.1007/s00213-016-4362-2. Epub 2016 Jul 6.

20.

Nicotinic receptors in the ventral tegmental area promote uncertainty-seeking.

Naudé J, Tolu S, Dongelmans M, Torquet N, Valverde S, Rodriguez G, Pons S, Maskos U, Mourot A, Marti F, Faure P.

Nat Neurosci. 2016 Mar;19(3):471-8. doi: 10.1038/nn.4223. Epub 2016 Jan 18.

PMID:
26780509
21.

Role of β4* Nicotinic Acetylcholine Receptors in the Habenulo-Interpeduncular Pathway in Nicotine Reinforcement in Mice.

Harrington L, Viñals X, Herrera-Solís A, Flores A, Morel C, Tolu S, Faure P, Maldonado R, Maskos U, Robledo P.

Neuropsychopharmacology. 2016 Jun;41(7):1790-802. doi: 10.1038/npp.2015.346. Epub 2015 Nov 20.

22.

The multiple roles of the α7 nicotinic acetylcholine receptor in modulating glutamatergic systems in the normal and diseased nervous system.

Koukouli F, Maskos U.

Biochem Pharmacol. 2015 Oct 15;97(4):378-387. doi: 10.1016/j.bcp.2015.07.018. Epub 2015 Jul 20. Review.

PMID:
26206184
23.

The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptors.

Wieskopf JS, Mathur J, Limapichat W, Post MR, Al-Qazzaz M, Sorge RE, Martin LJ, Zaykin DV, Smith SB, Freitas K, Austin JS, Dai F, Zhang J, Marcovitz J, Tuttle AH, Slepian PM, Clarke S, Drenan RM, Janes J, Al Sharari S, Segall SK, Aasvang EK, Lai W, Bittner R, Richards CI, Slade GD, Kehlet H, Walker J, Maskos U, Changeux JP, Devor M, Maixner W, Diatchenko L, Belfer I, Dougherty DA, Su AI, Lummis SC, Imad Damaj M, Lester HA, Patapoutian A, Mogil JS.

Sci Transl Med. 2015 May 13;7(287):287ra72. doi: 10.1126/scitranslmed.3009986.

24.

Crucial role of nicotinic α5 subunit variants for Ca2+ fluxes in ventral midbrain neurons.

Sciaccaluga M, Moriconi C, Martinello K, Catalano M, Bermudez I, Stitzel JA, Maskos U, Fucile S.

FASEB J. 2015 Aug;29(8):3389-98. doi: 10.1096/fj.14-268102. Epub 2015 Apr 24.

25.

The nicotinic acetylcholine receptor: From molecular biology to cognition.

Changeux JP, Corringer PJ, Maskos U.

Neuropharmacology. 2015 Sep;96(Pt B):135-6. doi: 10.1016/j.neuropharm.2015.03.024. Epub 2015 Apr 1. No abstract available.

PMID:
25842243
26.

EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF.

Khayati F, Pérez-Cano L, Maouche K, Sadoux A, Boutalbi Z, Podgorniak MP, Maskos U, Setterblad N, Janin A, Calvo F, Lebbé C, Menashi S, Fernandez-Recio J, Mourah S.

Oncotarget. 2015;6(12):9766-80.

27.

EMMPRIN regulates β1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells.

Delyon J, Khayati F, Djaafri I, Podgorniak MP, Sadoux A, Setterblad N, Boutalbi Z, Maouche K, Maskos U, Menashi S, Lebbé C, Mourah S.

Exp Dermatol. 2015 Jun;24(6):443-8. doi: 10.1111/exd.12693. Epub 2015 Apr 16.

PMID:
25807898
28.

Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.

Lombardo S, Maskos U.

Neuropharmacology. 2015 Sep;96(Pt B):255-62. doi: 10.1016/j.neuropharm.2014.11.018. Epub 2014 Dec 13. Review.

29.

Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice.

Sanjakdar SS, Maldoon PP, Marks MJ, Brunzell DH, Maskos U, McIntosh JM, Bowers MS, Damaj MI.

Neuropsychopharmacology. 2015 Jan;40(2):350-60. doi: 10.1038/npp.2014.177. Epub 2014 Jul 18.

30.

The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization.

Moretti M, Zoli M, George AA, Lukas RJ, Pistillo F, Maskos U, Whiteaker P, Gotti C.

Mol Pharmacol. 2014 Sep;86(3):306-17. doi: 10.1124/mol.114.093377. Epub 2014 Jul 7.

31.

The α3β4* nicotinic ACh receptor subtype mediates physical dependence to morphine: mouse and human studies.

Muldoon PP, Jackson KJ, Perez E, Harenza JL, Molas S, Rais B, Anwar H, Zaveri NT, Maldonado R, Maskos U, McIntosh JM, Dierssen M, Miles MF, Chen X, De Biasi M, Damaj MI.

Br J Pharmacol. 2014 Aug;171(16):3845-57. doi: 10.1111/bph.12741.

32.

Concomitant alpha7 and beta2 nicotinic AChR subunit deficiency leads to impaired energy homeostasis and increased physical activity in mice.

Somm E, Guérardel A, Maouche K, Toulotte A, Veyrat-Durebex C, Rohner-Jeanrenaud F, Maskos U, Hüppi PS, Schwitzgebel VM.

Mol Genet Metab. 2014 May;112(1):64-72. doi: 10.1016/j.ymgme.2014.03.003. Epub 2014 Mar 19.

PMID:
24685552
33.

Nicotine consumption is regulated by a human polymorphism in dopamine neurons.

Morel C, Fattore L, Pons S, Hay YA, Marti F, Lambolez B, De Biasi M, Lathrop M, Fratta W, Maskos U, Faure P.

Mol Psychiatry. 2014 Aug;19(8):930-6. doi: 10.1038/mp.2013.158. Epub 2013 Dec 3.

PMID:
24296975
34.

Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signaling.

Collo G, Bono F, Cavalleri L, Plebani L, Mitola S, Merlo Pich E, Millan MJ, Zoli M, Maskos U, Spano P, Missale C.

Mol Pharmacol. 2013 Jun;83(6):1176-89. doi: 10.1124/mol.113.084863. Epub 2013 Mar 29.

PMID:
23543412
35.

Contribution of α7 nicotinic receptor to airway epithelium dysfunction under nicotine exposure.

Maouche K, Medjber K, Zahm JM, Delavoie F, Terryn C, Coraux C, Pons S, Cloëz-Tayarani I, Maskos U, Birembaut P, Tournier JM.

Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4099-104. doi: 10.1073/pnas.1216939110. Epub 2013 Feb 19.

36.

Disinhibition goes up in smoke.

Marti F, Maskos U, Faure P.

Mol Psychiatry. 2013 Mar;18(3):267. doi: 10.1038/mp.2013.14. No abstract available.

PMID:
23426203
37.

Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement.

Tolu S, Eddine R, Marti F, David V, Graupner M, Pons S, Baudonnat M, Husson M, Besson M, Reperant C, Zemdegs J, Pagès C, Hay YA, Lambolez B, Caboche J, Gutkin B, Gardier AM, Changeux JP, Faure P, Maskos U.

Mol Psychiatry. 2013 Mar;18(3):382-93. doi: 10.1038/mp.2012.83. Epub 2012 Jul 3.

PMID:
22751493
38.

Selective re-expression of β2 nicotinic acetylcholine receptor subunits in the ventral tegmental area of the mouse restores intravenous nicotine self-administration.

Orejarena MJ, Herrera-Solís A, Pons S, Maskos U, Maldonado R, Robledo P.

Neuropharmacology. 2012 Aug;63(2):235-41. doi: 10.1016/j.neuropharm.2012.03.011. Epub 2012 Mar 28.

PMID:
22480616
39.

Striatal α5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum.

Exley R, McIntosh JM, Marks MJ, Maskos U, Cragg SJ.

J Neurosci. 2012 Feb 15;32(7):2352-6. doi: 10.1523/JNEUROSCI.4985-11.2012.

40.

Nicotinic acetylcholine receptor β2 subunits in the medial prefrontal cortex control attention.

Guillem K, Bloem B, Poorthuis RB, Loos M, Smit AB, Maskos U, Spijker S, Mansvelder HD.

Science. 2011 Aug 12;333(6044):888-91. doi: 10.1126/science.1207079.

41.

Modulation of the mouse prefrontal cortex activation by neuronal nicotinic receptors during novelty exploration but not by exploration of a familiar environment.

Bourgeois JP, Meas-Yeadid V, Lesourd AM, Faure P, Pons S, Maskos U, Changeux JP, Olivo-Marin JC, Granon S.

Cereb Cortex. 2012 May;22(5):1007-15. doi: 10.1093/cercor/bhr159. Epub 2011 Aug 1.

PMID:
21810785
42.

Smoke extracts and nicotine, but not tobacco extracts, potentiate firing and burst activity of ventral tegmental area dopaminergic neurons in mice.

Marti F, Arib O, Morel C, Dufresne V, Maskos U, Corringer PJ, de Beaurepaire R, Faure P.

Neuropsychopharmacology. 2011 Oct;36(11):2244-57. doi: 10.1038/npp.2011.112. Epub 2011 Jun 29.

43.

Aversion to nicotine is regulated by the balanced activity of β4 and α5 nicotinic receptor subunits in the medial habenula.

Frahm S, Slimak MA, Ferrarese L, Santos-Torres J, Antolin-Fontes B, Auer S, Filkin S, Pons S, Fontaine JF, Tsetlin V, Maskos U, Ibañez-Tallon I.

Neuron. 2011 May 12;70(3):522-35. doi: 10.1016/j.neuron.2011.04.013.

44.

Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+.

Toulorge D, Guerreiro S, Hild A, Maskos U, Hirsch EC, Michel PP.

FASEB J. 2011 Aug;25(8):2563-73. doi: 10.1096/fj.11-182824. Epub 2011 Apr 20.

PMID:
21507900
45.

Distinct contributions of nicotinic acetylcholine receptor subunit alpha4 and subunit alpha6 to the reinforcing effects of nicotine.

Exley R, Maubourguet N, David V, Eddine R, Evrard A, Pons S, Marti F, Threlfell S, Cazala P, McIntosh JM, Changeux JP, Maskos U, Cragg SJ, Faure P.

Proc Natl Acad Sci U S A. 2011 May 3;108(18):7577-82. doi: 10.1073/pnas.1103000108. Epub 2011 Apr 18.

46.

Prefrontal nicotinic receptors control novel social interaction between mice.

Avale ME, Chabout J, Pons S, Serreau P, De Chaumont F, Olivo-Marin JC, Bourgeois JP, Maskos U, Changeux JP, Granon S.

FASEB J. 2011 Jul;25(7):2145-55. doi: 10.1096/fj.10-178558. Epub 2011 Mar 14.

PMID:
21402717
47.

α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6ß4 and α6ß2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release.

Azam L, Maskos U, Changeux JP, Dowell CD, Christensen S, De Biasi M, McIntosh JM.

FASEB J. 2010 Dec;24(12):5113-23. doi: 10.1096/fj.10-166272. Epub 2010 Aug 25.

48.

Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors.

Melis M, Carta S, Fattore L, Tolu S, Yasar S, Goldberg SR, Fratta W, Maskos U, Pistis M.

Biol Psychiatry. 2010 Aug 1;68(3):256-64. doi: 10.1016/j.biopsych.2010.04.016. Epub 2010 Jun 8.

49.

Role of endogenous acetylcholine in the control of the dopaminergic system via nicotinic receptors.

Maskos U.

J Neurochem. 2010 Aug;114(3):641-6. doi: 10.1111/j.1471-4159.2010.06798.x. Epub 2010 May 4. Review.

50.

Effect of the alpha4beta2* nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in beta2 knock-out mice with selective re-expression of the beta2 subunit in the ventral tegmental area.

Reperant C, Pons S, Dufour E, Rollema H, Gardier AM, Maskos U.

Neuropharmacology. 2010 Feb;58(2):346-50. doi: 10.1016/j.neuropharm.2009.10.007. Epub 2009 Nov 1.

PMID:
19887076

Supplemental Content

Loading ...
Support Center